Cancer drug delivery in the nano era: An overview and perspectives

Nanomaterials are increasingly used as drug carriers for cancer therapy. Nanomaterials also appeal to researchers in the areas of cancer diagnosis and biomarker discovery. Several antitumor nanodrugs are currently being tested in preclinical and clinical trials and show promise in therapeutic and other settings. We review the development of nanomaterial drug carriers, including liposomes, polymer nanoparticles, dendritic polymers, and nanomicelles, for the diagnosis and treatment of various cancers. The prospects of nanomaterials as drug carriers for future clinical applications are also discussed.

[1]  K. Hynynen,et al.  To heat or not to heat: Challenges with clinical translation of thermosensitive liposomes , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[2]  Changping Wang,et al.  Biodegradable Smart Nanogels: A New Platform for Targeting Drug Delivery and Biomedical Diagnostics. , 2016, Langmuir : the ACS journal of surfaces and colloids.

[3]  J. Cortes,et al.  Final results of a phase III randomized trial of CPX-351 versus 7+3 in older patients with newly diagnosed high risk (secondary) AML. , 2016 .

[4]  Ying Zhang,et al.  Construction of near-infrared light-triggered reactive oxygen species-sensitive (UCN/SiO2-RB + DOX)@PPADT nanoparticles for simultaneous chemotherapy and photodynamic therapy , 2016, Nanotechnology.

[5]  D. Yan,et al.  Dendritic Polymers for Theranostics , 2016, Theranostics.

[6]  Preeti Kumari,et al.  Recent advances in polymeric micelles for anti-cancer drug delivery. , 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[7]  O. Farokhzad,et al.  Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release. , 2016, Chemical reviews.

[8]  Glen J Weiss,et al.  Phase I Study of PSMA-Targeted Docetaxel-Containing Nanoparticle BIND-014 in Patients with Advanced Solid Tumors , 2016, Clinical Cancer Research.

[9]  Wei Wu,et al.  Synchronous microencapsulation of multiple components in silymarin into PLGA nanoparticles by an emulsification/solvent evaporation method , 2015, Pharmaceutical development and technology.

[10]  Chao Zhang,et al.  Enhanced antitumor efficacy by cyclic RGDyK-conjugated and paclitaxel-loaded pH-responsive polymeric micelles. , 2015, Acta biomaterialia.

[11]  Ronnie H. Fang,et al.  Nanoparticle biointerfacing via platelet membrane cloaking , 2015, Nature.

[12]  S. N. Murthy,et al.  Novel Redox-Responsive Amphiphilic Copolymer Micelles for Drug Delivery: Synthesis and Characterization , 2015, The AAPS Journal.

[13]  Haliza Katas,et al.  Stability, Intracellular Delivery, and Release of siRNA from Chitosan Nanoparticles Using Different Cross-Linkers , 2015, PloS one.

[14]  Won Jong Kim,et al.  Visible light-induced singlet oxygen-mediated intracellular disassembly of polymeric micelles co-loaded with a photosensitizer and an anticancer drug for enhanced photodynamic therapy. , 2015, Chemical communications.

[15]  Peiyi Wu,et al.  Aqueous Solutions of Poly(ethylene oxide)-Poly(N-isopropylacrylamide): Thermosensitive Behavior and Distinct Multiple Assembly Processes. , 2015, Langmuir : the ACS journal of surfaces and colloids.

[16]  V. Torchilin,et al.  New Developments in Liposomal Drug Delivery. , 2015, Chemical reviews.

[17]  Pegylated liposomal doxorubicin (Lipo-Dox®) combined with cyclophosphamide and 5-fluorouracil is effective and safe as salvage chemotherapy in taxane-treated metastatic breast cancer: an open-label, multi-center, non-comparative phase II study , 2015, BMC Cancer.

[18]  I. Vergote,et al.  Randomized phase III study comparing paclical-carboplatin with paclitaxel-carboplatin in patients with recurrent platinum-sensitive epithelial ovarian cancer. , 2015 .

[19]  N. Sugimoto,et al.  A phase II study of NK012, a polymeric micelle formulation of SN-38, in colorectal cancer patients who had received prior oxaliplatin-based regimen. , 2015 .

[20]  Xiaoqin Wang,et al.  A single dose of dexamethasone encapsulated in polyethylene glycol-coated polylactic acid nanoparticles attenuates cisplatin-induced hearing loss following round window membrane administration , 2015, International journal of nanomedicine.

[21]  X. Banquy,et al.  Effect of the Polymer Architecture on the Structural and Biophysical Properties of PEG-PLA Nanoparticles. , 2015, ACS applied materials & interfaces.

[22]  Xiangyang Shi,et al.  Dendrimer-based molecular imaging contrast agents , 2015 .

[23]  Thomas K. Schulz,et al.  A phase I study of intraperitoneal nanoparticulate paclitaxel (Nanotax®) in patients with peritoneal malignancies , 2015, Cancer Chemotherapy and Pharmacology.

[24]  A method to Quantify the Affinity of Cabazitaxel for PLA-PEG Nanoparticles and Investigate the Influence of the Nano-Assembly Structure on the Drug/Particle Association , 2015, Pharmaceutical Research.

[25]  Yong Gao,et al.  A novel glycyrrhetinic acid-modified oxaliplatin liposome for liver-targeting and in vitro/vivo evaluation , 2015, Drug design, development and therapy.

[26]  Lixia Peng,et al.  Surface modification of MPEG-b-PCL-based nanoparticles via oxidative self-polymerization of dopamine for malignant melanoma therapy , 2015, International journal of nanomedicine.

[27]  Feifei Zhao,et al.  Multi-functional liposomes showing radiofrequency-triggered release and magnetic resonance imaging for tumor multi-mechanism therapy. , 2015, Nanoscale.

[28]  Han Wang,et al.  Conjugation of iron oxide nanoparticles with RGD-modified dendrimers for targeted tumor MR imaging. , 2015, ACS applied materials & interfaces.

[29]  Jong Hwa Jung,et al.  Enhanced NIR radiation-triggered hyperthermia by mitochondrial targeting. , 2015, Journal of the American Chemical Society.

[30]  Yi Yan Yang,et al.  A novel chemosynthetic peptide with β-sheet motif efficiently kills Klebsiella pneumoniae in a mouse model , 2015, International journal of nanomedicine.

[31]  C. Sgarlata,et al.  Novel amino-cyclodextrin cross-linked oligomer as efficient carrier for anionic drugs: a spectroscopic and nanocalorimetric investigation , 2015 .

[32]  J. Verma,et al.  Inorganic nanoparticles for the theranostics of cancer , 2015 .

[33]  Shichao Wu,et al.  Evaluation of self-assembled HCPT-loaded PEG-b-PLA nanoparticles by comparing with HCPT-loaded PLA nanoparticles , 2014, Nanoscale Research Letters.

[34]  M. Çetin,et al.  Chitosan-poly (lactide-co-glycolide) (CS-PLGA) nanoparticles containing metformin HCl: preparation and in vitro evaluation. , 2014, Pakistan journal of pharmaceutical sciences.

[35]  Mark E. Davis,et al.  Correlating animal and human phase Ia/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA , 2014, Proceedings of the National Academy of Sciences.

[36]  Triantafyllos Stylianopoulos,et al.  The role of mechanical forces in tumor growth and therapy. , 2014, Annual review of biomedical engineering.

[37]  Yu Wang,et al.  Fluorinated poly(propylenimine) dendrimers as gene vectors. , 2014, Biomaterials.

[38]  Viney Lather,et al.  Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues , 2014, Journal of pharmacy & bioallied sciences.

[39]  Yuquan Wei,et al.  Legumain protease-activated TAT-liposome cargo for targeting tumours and their microenvironment , 2014, Nature Communications.

[40]  Yan Chen,et al.  Statistical modeling of the drug load distribution on trastuzumab emtansine (Kadcyla), a lysine-linked antibody drug conjugate. , 2014, Bioconjugate chemistry.

[41]  K. Kataoka,et al.  Assessment of antitumor activity and acute peripheral neuropathy of 1,2-diaminocyclohexane platinum (II)-incorporating micelles (NC-4016) , 2014, International journal of nanomedicine.

[42]  E. Cho,et al.  A phase II trial of Cremorphor EL-free paclitaxel (Genexol-PM) and gemcitabine in patients with advanced non-small cell lung cancer , 2014, Cancer Chemotherapy and Pharmacology.

[43]  R. Simão,et al.  Analysis of asphaltic binders modified with PPA by surface techniques , 2014, Journal of microscopy.

[44]  S. Lippard,et al.  Pt(IV) Prodrugs Designed to Bind Non-Covalently to Human Serum Albumin for Drug Delivery , 2014, Journal of the American Chemical Society.

[45]  R. Cavalli,et al.  The application of nanosponges to cancer drug delivery , 2014, Expert opinion on drug delivery.

[46]  Anaïs Pitto‐Barry,et al.  Pluronic® block-copolymers in medicine: from chemical and biological versatility to rationalisation and clinical advances , 2014 .

[47]  M. Piccart,et al.  A randomized controlled phase II trial of a novel composition of paclitaxel embedded into neutral and cationic lipids targeting tumor endothelial cells in advanced triple-negative breast cancer (TNBC). , 2014 .

[48]  M. Piccart,et al.  A randomized controlled phase II trial of a novel composition of paclitaxel embedded into neutral and cationic lipids targeting tumor endothelial cells in advanced triple-negative breast cancer (TNBC). , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[49]  K. Anoop,et al.  Smart polymers for the controlled delivery of drugs – a concise overview , 2014, Acta pharmaceutica Sinica. B.

[50]  Keerti Jain,et al.  Dendrimer as nanocarrier for drug delivery , 2014 .

[51]  L. A. Muehlmann,et al.  Perspectives on the application of nanotechnology in photodynamic therapy for the treatment of melanoma , 2014, Nano reviews.

[52]  S. Mozumdar,et al.  Synthesis of thermoresponsive polymers for drug delivery. , 2014, Methods in molecular biology.

[53]  Jonathan D. Ashley,et al.  Ligand-targeted liposome design: challenges and fundamental considerations. , 2014, Trends in biotechnology.

[54]  S. Prakash,et al.  Intranasal delivery of chitosan-siRNA nanoparticle formulation to the brain. , 2014, Methods in molecular biology.

[55]  H. Tajmir-Riahi,et al.  Applications of chitosan nanoparticles in drug delivery. , 2014, Methods in molecular biology.

[56]  Ming Zhou,et al.  A Mitochondria‐Targeting Gold–Peptide Nanoassembly for Enhanced Cancer‐Cell Killing , 2013, Advanced healthcare materials.

[57]  Ronnie H. Fang,et al.  Nanoparticle-detained toxins for safe and effective vaccination , 2013, Nature nanotechnology.

[58]  G. Zhai,et al.  Polymer-drug conjugates: present state of play and future perspectives. , 2013, Drug discovery today.

[59]  H. Rosing,et al.  Bioequivalence of Liposome-Entrapped Paclitaxel Easy-To-Use (LEP-ETU) formulation and paclitaxel in polyethoxylated castor oil: a randomized, two-period crossover study in patients with advanced cancer. , 2013, Clinical therapeutics.

[60]  Ben J Boyd,et al.  Prodrug and nanomedicine approaches for the delivery of the camptothecin analogue SN38. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[61]  Wenbin Lin,et al.  Application of liposomal technologies for delivery of platinum analogs in oncology , 2013, International journal of nanomedicine.

[62]  E. Marin,et al.  Critical evaluation of biodegradable polymers used in nanodrugs , 2013, International journal of nanomedicine.

[63]  Susan O'Brien,et al.  Phase I/II trial of nanomolecular liposomal annamycin in adult patients with relapsed/refractory acute lymphoblastic leukemia. , 2013, Clinical lymphoma, myeloma & leukemia.

[64]  N. Ohkohchi,et al.  NC‐6300, an epirubicin‐incorporating micelle, extends the antitumor effect and reduces the cardiotoxicity of epirubicin , 2013, Cancer science.

[65]  Ru Cheng,et al.  Acetal-linked paclitaxel prodrug micellar nanoparticles as a versatile and potent platform for cancer therapy. , 2013, Biomacromolecules.

[66]  T. Nguyen,et al.  Characteristics of curcumin-loaded poly (lactic acid) nanofibers for wound healing , 2013, Journal of Materials Science.

[67]  Jianfeng Chen,et al.  Poly(amidoamine) dendrimer-grafted porous hollow silica nanoparticles for enhanced intracellular photodynamic therapy. , 2013, Acta biomaterialia.

[68]  Johnson V. John,et al.  Dual stimuli-responsive poly(N-isopropylacrylamide)-b-poly(L-histidine) chimeric materials for the controlled delivery of doxorubicin into liver carcinoma. , 2013, Biomacromolecules.

[69]  Q. Shen,et al.  Fragment-based drug design and identification of HJC0123, a novel orally bioavailable STAT3 inhibitor for cancer therapy. , 2013, European journal of medicinal chemistry.

[70]  Ronnie H. Fang,et al.  A biomimetic nanosponge that absorbs pore-forming toxins , 2013, Nature nanotechnology.

[71]  M. Zloh,et al.  Cationic poly-L-lysine dendrimer complexes doxorubicin and delays tumor growth in vitro and in vivo. , 2013, ACS nano.

[72]  Zhuang Liu,et al.  Upconversion Nanoparticles for Photodynamic Therapy and Other Cancer Therapeutics , 2013, Theranostics.

[73]  S. Timur,et al.  Modified gold surfaces by 6-(ferrocenyl)hexanethiol/dendrimer/gold nanoparticles as a platform for the mediated biosensing applications. , 2013, Materials science & engineering. C, Materials for biological applications.

[74]  K. Kataoka,et al.  Tumor‐targeted chemotherapy with the nanopolymer‐based drug NC‐6004 for oral squamous cell carcinoma , 2013, Cancer science.

[75]  R. Zhang,et al.  Synthesis and evaluation of a backbone biodegradable multiblock HPMA copolymer nanocarrier for the systemic delivery of paclitaxel. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[76]  Rathindra Mohan Banik,et al.  Development of ciprofloxacin hydrochloride loaded poly(ethylene glycol)/chitosan scaffold as wound dressing , 2013, Journal of Porous Materials.

[77]  J. Silverman,et al.  Marqibo® (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine , 2012, Cancer Chemotherapy and Pharmacology.

[78]  S. Svenson,et al.  Clinical translation of nanomedicines , 2012 .

[79]  Andreas Wicki,et al.  Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study. , 2012, The Lancet. Oncology.

[80]  T. Matsushima,et al.  Organic nonvolatile memory transistors based on fullerene and an electron-trapping polymer , 2012 .

[81]  Qiang Zhang,et al.  The use of a tumor metastasis targeting peptide to deliver doxorubicin-containing liposomes to highly metastatic cancer. , 2012, Biomaterials.

[82]  Muthu Kumara Gnanasammandhan,et al.  In vivo photodynamic therapy using upconversion nanoparticles as remote-controlled nanotransducers , 2012, Nature Medicine.

[83]  Jennifer H. Grossman,et al.  Nanotechnology in Cancer Medicine , 2012 .

[84]  Erik C. Dreaden,et al.  Size matters: gold nanoparticles in targeted cancer drug delivery. , 2012, Therapeutic delivery.

[85]  Zhen Cheng,et al.  In vitro and in vivo uncaging and bioluminescence imaging by using photocaged upconversion nanoparticles. , 2012, Angewandte Chemie.

[86]  Omid C Farokhzad,et al.  Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. , 2012, Chemical Society reviews.

[87]  Yanling Luo,et al.  Studies on micellization behavior of thermosensitive PNIPAAm-b-PLA amphiphilic block copolymers. , 2012, Journal of nanoscience and nanotechnology.

[88]  Min Jae Lee,et al.  Liposome-Mediated Cancer Gene Therapy: Clinical Trials and their Lessons to Stem Cell Therapy , 2012 .

[89]  R. Zhuo,et al.  Synthesis of thermo- and pH-sensitive polyion complex micelles for fluorescent imaging. , 2012, Chemistry.

[90]  Molly S. Shoichet,et al.  Polymeric micelle stability , 2012 .

[91]  T. Boulikas,et al.  Lipoplatin Formulation Review Article , 2011, Journal of drug delivery.

[92]  K. Giese,et al.  Phase I clinical development of Atu027, a siRNA formulation targeting PKN3 in patients with advanced solid tumors. , 2012, International journal of clinical pharmacology and therapeutics.

[93]  T. Yoshikawa,et al.  Phase II study of NK105, a paclitaxel-incorporating micellar nanoparticle, for previously treated advanced or recurrent gastric cancer , 2012, Investigational New Drugs.

[94]  P. Opanasopit,et al.  Nanostructured Lipid Carriers (NLC) for Parenteral Delivery of an Anticancer Drug , 2011, AAPS PharmSciTech.

[95]  G. Shapiro,et al.  Abstract A89: A phase I study of the novel DNA topoisomerase-1 inhibitor, TLC388 (Lipotecan®), administered intravenously to patients with advanced solid tumors. , 2011 .

[96]  Kaushal Rege,et al.  Inorganic nanoparticles for cancer imaging and therapy. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[97]  L. Faccioli,et al.  The uptake of PLGA micro or nanoparticles by macrophages provokes distinct in vitro inflammatory response. , 2011, International immunopharmacology.

[98]  K. Tachibana,et al.  Combination of ultrasound and bubble liposome enhance the effect of doxorubicin and inhibit murine osteosarcoma growth , 2011, Cancer biology & therapy.

[99]  Y. Namiki,et al.  Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring. , 2011, Accounts of chemical research.

[100]  K. Rostamizadeh,et al.  Preparation of biodegradable nanoparticles of tri-block PLA–PEG–PLA copolymer and determination of factors controlling the particle size using artificial neural network , 2011, Journal of microencapsulation.

[101]  Srikanth K. Iyer,et al.  Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma. , 2011, The Journal of clinical investigation.

[102]  Omid C Farokhzad,et al.  Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation. , 2011, Accounts of chemical research.

[103]  Ronnie H. Fang,et al.  Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform , 2011, Proceedings of the National Academy of Sciences.

[104]  M. Popall,et al.  Applications of Advanced Hybrid Organic—Inorganic Nanomaterials: From Laboratory to Market , 2011 .

[105]  Darrell J Irvine,et al.  Drug delivery: One nanoparticle, one kill. , 2011, Nature materials.

[106]  Sokbom Kang,et al.  Phase II study of belotecan (CKD 602) as a single agent in patients with recurrent or progressive carcinoma of uterine cervix. , 2011, Japanese journal of clinical oncology.

[107]  M. Nishio,et al.  Safety of BLP25 liposome vaccine (L-BLP25) in Japanese patients with unresectable stage III NSCLC after primary chemoradiotherapy: preliminary results from a Phase I/II study. , 2011, Japanese journal of clinical oncology.

[108]  Arenst Andreas Arie,et al.  Effect of boron doped fullerene C60 film coating on the electrochemical characteristics of silicon thin film anodes for lithium secondary batteries , 2011 .

[109]  A. Alwan.  Global status report on noncommunicable diseases 2010. , 2011 .

[110]  Hillary Holback,et al.  Intratumoral Drug Delivery with Nanoparticulate Carriers , 2011, Pharmaceutical Research.

[111]  Robert Langer,et al.  On firm ground: IP protection of therapeutic nanoparticles , 2010, Nature Biotechnology.

[112]  R. Jain,et al.  Delivering nanomedicine to solid tumors , 2010, Nature Reviews Clinical Oncology.

[113]  M. Dadsetan,et al.  In vivo biodegradation and biocompatibility of PEG/sebacic acid-based hydrogels using a cage implant system. , 2010, Journal of biomedical materials research. Part A.

[114]  Archana Nigam,et al.  A Fluorinated Dendrimer-Based Nanotechnology Platform: New Contrast Agents for High Field Imaging , 2010, Investigative radiology.

[115]  Lawrence Tamarkin,et al.  Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine , 2010, Clinical Cancer Research.

[116]  A. S. Moses,et al.  Imaging and drug delivery using theranostic nanoparticles. , 2010, Advanced drug delivery reviews.

[117]  P. Kesharwani,et al.  Dendrimer toxicity: Let's meet the challenge. , 2010, International journal of pharmaceutics.

[118]  Kenneth C. Anderson,et al.  Dual Inhibition of Akt/Mammalian Target of Rapamycin Pathway by Nanoparticle Albumin-Bound–Rapamycin and Perifosine Induces Antitumor Activity in Multiple Myeloma , 2010, Molecular Cancer Therapeutics.

[119]  Mark E. Davis,et al.  Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles , 2010, Nature.

[120]  N. Senzer,et al.  Abstract C36: MBP‐426, a novel liposome‐encapsulated oxaliplatin, in combination with 5‐FU/leucovorin (LV): Phase I results of a Phase I/II study in gastro‐esophageal adenocarcinoma, with pharmacokinetics , 2009 .

[121]  Xun Sun,et al.  A randomized multicenter phase II clinical trial of mitoxantrone-loaded nanoparticles in the treatment of 108 patients with unresected hepatocellular carcinoma. , 2009, Nanomedicine : nanotechnology, biology, and medicine.

[122]  Elizabeth R Gillies,et al.  A cascade biodegradable polymer based on alternating cyclization and elimination reactions. , 2009, Journal of the American Chemical Society.

[123]  Jin Sun,et al.  Nanoparticle albumin-bound (NAB) technology is a promising method for anti-cancer drug delivery. , 2009, Recent patents on anti-cancer drug discovery.

[124]  James R Baker,et al.  Targeting and detecting cancer cells using spontaneously formed multifunctional dendrimer-stabilized gold nanoparticles. , 2009, The Analyst.

[125]  J. Hainsworth,et al.  A phase II study of single agent OSI-7904L in patients with metastatic or recurrent squamous cell carcinoma of the head and neck (SCCHN). , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[126]  L. Kaminskas,et al.  Pharmacokinetics and tumor disposition of PEGylated, methotrexate conjugated poly-l-lysine dendrimers. , 2009, Molecular pharmaceutics.

[127]  Peter H Lin,et al.  Current advances in research and clinical applications of PLGA-based nanotechnology , 2009, Expert review of molecular diagnostics.

[128]  E. Miele,et al.  Albumin-bound formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancer , 2009, International journal of nanomedicine.

[129]  N. K. Jain,et al.  Dendimer-mediated solubilization, formulation development and in vitro-in vivo assessment of piroxicam. , 2009, Molecular pharmaceutics.

[130]  Robert Langer,et al.  Impact of nanotechnology on drug delivery. , 2009, ACS nano.

[131]  V. Rotello,et al.  Nano-conjugate fluorescence probe for the discrimination of phosphate and pyrophosphate. , 2009, Chemistry.

[132]  Chaoliang He,et al.  Synthesis of Novel Thermo‐ and pH‐Responsive Poly(L‐lysine)‐Based Copolymer and its Micellization in Water , 2008 .

[133]  Sandra C. Mwakwari,et al.  Historic perspective on the use of AuNPs in medicine , 2008 .

[134]  H. Mao,et al.  Self-assembled biodegradable micellar nanoparticles of amphiphilic and cationic block copolymer for siRNA delivery. , 2008, Biomaterials.

[135]  Xuesi Chen,et al.  Formation of reversible shell cross-linked micelles from the biodegradable amphiphilic diblock copolymer poly(L-cysteine)-block-poly(L-lactide). , 2008, Langmuir : the ACS journal of surfaces and colloids.

[136]  Patrick Soon-Shiong,et al.  Protein nanoparticles as drug carriers in clinical medicine. , 2008, Advanced drug delivery reviews.

[137]  Chaoliang He,et al.  Novel pH- and Temperature-Responsive Block Copolymers with Tunable pH-Responsive Range , 2008 .

[138]  Thommey P. Thomas,et al.  Dendrimer-epidermal growth factor conjugate displays superagonist activity. , 2008, Biomacromolecules.

[139]  Kelly Y. Kim.  Nanotechnology platforms and physiological challenges for cancer therapeutics. , 2017, Nanomedicine : nanotechnology, biology, and medicine.

[140]  J. Belmont,et al.  Liposome-incorporated Grb2 antisense oligodeoxynucleotide increases the survival of mice bearing bcr-abl-positive leukemia xenografts. , 2007, International journal of oncology.

[141]  J. Baker,et al.  Synthetic PAMAM-RGD conjugates target and bind to odontoblast-like MDPC 23 cells and the predentin in tooth organ cultures. , 2007, Bioconjugate chemistry.

[142]  M. Stoffel,et al.  Mechanisms and optimization of in vivo delivery of lipophilic siRNAs , 2007, Nature Biotechnology.

[143]  T. Deming.  Synthetic polypeptides for biomedical applications , 2007 .

[144]  Chunzhong Li,et al.  An enhanced biosensor for glutamate based on self-assembled carbon nanotubes and dendrimer-encapsulated platinum nanobiocomposites-doped polypyrrole film. , 2007, Analytica chimica acta.

[145]  A. Hutson,et al.  Synthesis and Characterization of PAMAM Dendrimer-Based Multifunctional Nanodevices for Targeting αvβ3 Integrins , 2007 .

[146]  H. Sawada,et al.  Synthesis and applications of novel fluorinated dendrimer-type copolymers by the use of fluoroalkanoyl peroxide as a key intermediate. , 2007, Journal of colloid and interface science.

[147]  Guo-Li Shen,et al.  Functionalization of multi-walled carbon nanotubes with poly(amidoamine) dendrimer for mediator-free glucose biosensor , 2007 .

[148]  A. Hutson,et al.  Synthesis and characterization of PAMAM dendrimer-based multifunctional nanodevices for targeting alphavbeta3 integrins. , 2007, Bioconjugate chemistry.

[149]  F. Dosio,et al.  Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential , 2006, International journal of nanomedicine.

[150]  M J Hawkins,et al.  Abraxane, a novel Cremophor-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[151]  Maurie Markman,et al.  Pegylated liposomal doxorubicin in the treatment of cancers of the breast and ovary , 2006, Expert opinion on pharmacotherapy.

[152]  Michael R Hamblin,et al.  Photodynamic therapy and anti-tumour immunity , 2006, Nature Reviews Cancer.

[153]  Long Yu,et al.  Polymer blends and composites from renewable resources , 2006 .

[154]  D. V. Hoff,et al.  A Phase 2 trial of the liposomal DACH platinum L-NDDP in patients with therapy-refractory advanced colorectal cancer , 2006, Cancer Chemotherapy and Pharmacology.

[155]  Charles A Vacanti,et al.  Polyglycolic acid-induced inflammation: role of hydrolysis and resulting complement activation. , 2006, Tissue engineering.

[156]  T. Boulikas,et al.  Liposomal oxaliplatin in the treatment of advanced cancer: a phase I study. , 2006, Anticancer research.

[157]  Francis C Szoka,et al.  Designing dendrimers for biological applications , 2005, Nature Biotechnology.

[158]  Costas Demetzos,et al.  Doxorubicin-PAMAM dendrimer complex attached to liposomes: cytotoxic studies against human cancer cell lines. , 2005, International journal of pharmaceutics.

[159]  Anil K Sood,et al.  Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery. , 2005, Cancer research.

[160]  S Moein Moghimi,et al.  A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[161]  M. Chevallier,et al.  Increase of doxorubicin sensitivity by doxorubicin-loading into nanoparticles for hepatocellular carcinoma cells in vitro and in vivo. , 2005, Journal of hepatology.

[162]  K. Edwards,et al.  Optimization and characterization of a sphingomyelin/cholesterol liposome formulation of vinorelbine with promising antitumor activity. , 2005, Journal of pharmaceutical sciences.

[163]  Bruce Miller,et al.  Preparation, Characterization, and Stability of Liposome-Based Formulations of Mitoxantrone , 2005, Drug development and industrial pharmacy.

[164]  J. Fréchet,et al.  Dendrimers and dendritic polymers in drug delivery. , 2005, Drug discovery today.

[165]  R. Macdonald,et al.  Acoustically active liposomes for drug encapsulation and ultrasound-triggered release. , 2004, Biochimica et biophysica acta.

[166]  Thommey P. Thomas,et al.  In vitro targeting of synthesized antibody-conjugated dendrimer nanoparticles. , 2004, Biomacromolecules.

[167]  E. Simanek,et al.  Cytotoxicity, hemolysis, and acute in vivo toxicity of dendrimers based on melamine, candidate vehicles for drug delivery. , 2004, Journal of the American Chemical Society.

[168]  U. Matulonis,et al.  A phase II study of liposomal lurtotecan (OSI-211) in patients with topotecan resistant ovarian cancer. , 2004, Gynecologic oncology.

[169]  Thommey P. Thomas,et al.  Design and Function of a Dendrimer-Based Therapeutic Nanodevice Targeted to Tumor Cells Through the Folate Receptor , 2002, Pharmaceutical Research.

[170]  Robert Langer,et al.  Small-scale systems for in vivo drug delivery , 2003, Nature Biotechnology.

[171]  Qian Peng,et al.  An outline of the hundred-year history of PDT. , 2003, Anticancer research.

[172]  S Sridevi,et al.  Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[173]  Kevin E Healy,et al.  Nanoparticulate DNA packaging using terpolymers of poly(lysine-g-(lactide-b-ethylene glycol)). , 2003, Bioconjugate chemistry.

[174]  Frank Caruso,et al.  Effect of dendrimer on entrapment and release of bioactive from liposomes. , 2002, International journal of pharmaceutics.

[175]  P. Meers,et al.  Enzyme-activated targeting of liposomes. , 2001, Advanced drug delivery reviews.

[176]  A. Mueller,et al.  Photoinitiated destabilization of sterically stabilized liposomes. , 2001, Biochimica et biophysica acta.

[177]  G. Batist,et al.  Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[178]  T Sakthivel,et al.  Interaction of cationic partial dendrimers with charged and neutral liposomes. , 2001, International journal of pharmaceutics.

[179]  R. Duncan,et al.  Dendrimer-platinate: a novel approach to cancer chemotherapy. , 1999, Anti-cancer drugs.

[180]  David H. Thompson,et al.  Cytosolic drug delivery using pH- and light-sensitive liposomes. , 1999, Advanced drug delivery reviews.

[181]  P. Ahl,et al.  Elastase activated liposomal delivery to nucleated cells. , 1999, Biochimica et biophysica acta.

[182]  T. Okano,et al.  Preparation and characterization of thermally responsive block copolymer micelles comprising poly(N-isopropylacrylamide-b-DL-lactide). , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[183]  C. Miller,et al.  Liposome-cell interactions in vitro: effect of liposome surface charge on the binding and endocytosis of conventional and sterically stabilized liposomes. , 1998, Biochemistry.

[184]  Mandip Singh,et al.  Lipophilic drug derivatives in liposomes , 1998 .

[185]  V. Fingar,et al.  Vascular effects of photodynamic therapy. , 1996, Journal of clinical laser medicine & surgery.

[186]  Kaposi's sarcoma: DaunoXome approved. , 1996, AIDS treatment news.

[187]  V. Torchilin,et al.  Immunoliposomes and PEGylated immunoliposomes: possible use for targeted delivery of imaging agents. , 1994, ImmunoMethods.

[188]  D Tomlinson,et al.  Liposomal doxorubicin (Doxil): an effective new treatment for Kaposi's sarcoma in AIDS. , 1994, Clinical oncology (Royal College of Radiologists (Great Britain)).

[189]  R Langer,et al.  New methods of drug delivery. , 1990, Science.

[190]  J. Northrop,et al.  Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[191]  James R. Dewald,et al.  A New Class of Polymers: Starburst-Dendritic Macromolecules , 1985 .

[192]  G. Gregoriadis,et al.  Is half‐life of circulating liposomes determined by changes in their permeability? , 1982, FEBS letters.

[193]  T. Allen,et al.  Serum-induced leakage of liposome contents. , 1980, Biochimica et biophysica acta.

[194]  J. Parks,et al.  Disintegration of phosphatidylcholine liposomes in plasma as a result of interaction with high-density lipoproteins. , 1978, Biochimica et biophysica acta.

[195]  E. Buhleier,et al.  "Cascade"- and "Nonskid-Chain-like" Syntheses of Molecular Cavity Topologies , 1978 .

[196]  R. Langer,et al.  Polymers for the sustained release of proteins and other macromolecules , 1976, Nature.

[197]  K. Jacobson,et al.  Phase transitions in phospholipid vesicles. Fluorescence polarization and permeability measurements concerning the effect of temperature and cholesterol. , 1973, Biochimica et biophysica acta.

[198]  A. Bangham,et al.  Diffusion of univalent ions across the lamellae of swollen phospholipids. , 1965, Journal of molecular biology.